Levi-04, A Novel Neurotrophin-3 Inhibitor, Demonstrates Clinically Meaningful Improvements In Pain And Physical Function Across A Range Of Oa Outcomes, Including The Omeract-Oarsi Responder Criteria - Claire Herholdt